Mountain Valley MD Holdings Inc. announce the appointment of Sid Senroy as an advisor to the Company. In this capacity, Mr. Senroy will work with the leadership team on pharmaceutical licensing strategy, facilitate strategic introductions to key pharmaceutical partners and support the development of the Company's overall business development plan. Mr. Senroy is a seasoned pharmaceutical executive with an MBA from Pepperdine University with expertise in helping companies pass compliance assessments, develop robust quality systems and prepare for U.S. Food and Drug Administration reviews and inspections. Over the past two decades, Mr. Senroy has successfully led several global Quality and Compliance business units as an executive or senior consultant, leading to the approval of key blockbuster drugs with cumulative sales exceeding $30 billion annually over the last 10 years. Mr. Senroy's ability to form cross-functional alliances for improvement and growth, in addition to a sensitivity to cultural nuances, has helped him succeed on a global scale. He has worked extensively throughout North America, Europe, Asia and South America. Additionally, the Company announced the addition of Leigh Hughes as an advisor to the Company. Mr. Hughes will be supporting the Company's work in the areas of mergers and acquisitions, corporate finance and pharmaceutical licensing. Mr. Hughes brings over fifteen years of professional experience in integrated corporate and marketing communications and extensive experience in venture capital services and commercialization of private and public companies across the globe: North America, Australia, and the Asia Pacific Region.